These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24351802)

  • 1. Association of cognitive dysfunction with cardiovascular disease events in elderly hypertensive patients.
    Yano Y; Bakris GL; Inokuchi T; Ohba Y; Tamaki N; Nagata M; Kuwabara M; Yokota N; Eto T; Kuroki M; Shimada K; Kario K
    J Hypertens; 2014 Feb; 32(2):423-31. PubMed ID: 24351802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating des-acyl ghrelin improves cardiovascular risk prediction in older hypertensive patients.
    Yano Y; Nakazato M; Toshinai K; Inokuchi T; Matsuda S; Hidaka T; Hayakawa M; Kangawa K; Shimada K; Kario K
    Am J Hypertens; 2014 May; 27(5):727-33. PubMed ID: 24363280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Independent association of cognitive dysfunction with cardiac hypertrophy irrespective of 24-h or sleep blood pressure in older hypertensives.
    Hayakawa M; Yano Y; Kuroki K; Inoue R; Nakanishi C; Sagara S; Koga M; Kubo H; Imakiire S; Aoyagi Z; Kitani M; Kanemaru K; Hidehito S; Shimada K; Kario K
    Am J Hypertens; 2012 Jun; 25(6):657-63. PubMed ID: 22421907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sleep-time blood pressure: prognostic value and relevance as a therapeutic target for cardiovascular risk reduction.
    Hermida RC; Ayala DE; Fernández JR; Mojón A
    Chronobiol Int; 2013 Mar; 30(1-2):68-86. PubMed ID: 23181592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment and risk of cardiovascular events and mortality.
    O'Donnell M; Teo K; Gao P; Anderson C; Sleight P; Dans A; Marzona I; Bosch J; Probstfield J; Yusuf S
    Eur Heart J; 2012 Jul; 33(14):1777-86. PubMed ID: 22551598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circadian pattern of ambulatory blood pressure in hypertensive patients with and without type 2 diabetes.
    Ayala DE; Moyá A; Crespo JJ; Castiñeira C; Domínguez-Sardiña M; Gomara S; Sineiro E; Mojón A; Fontao MJ; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):99-115. PubMed ID: 23098178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risk of essential hypertension: influence of class, number, and treatment-time regimen of hypertension medications.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):315-27. PubMed ID: 23181712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systolic blood pressure variability is an important predictor of cardiovascular outcomes in elderly hypertensive patients.
    Chowdhury EK; Owen A; Krum H; Wing LM; Nelson MR; Reid CM;
    J Hypertens; 2014 Mar; 32(3):525-33. PubMed ID: 24481213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of time-of-day of hypertension treatment on the J-shaped relationship between blood pressure and cardiovascular risk.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):328-39. PubMed ID: 23181738
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The combination of chronic kidney disease and increased arterial stiffness is a predictor for stroke and cardiovascular disease in hypertensive patients.
    Ohishi M; Tatara Y; Ito N; Takeya Y; Onishi M; Maekawa Y; Kato N; Kamide K; Rakugi H
    Hypertens Res; 2011 Nov; 34(11):1209-15. PubMed ID: 21814210
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of ambulatory blood pressure parameters of hypertensive patients with and without chronic kidney disease.
    Mojón A; Ayala DE; Piñeiro L; Otero A; Crespo JJ; Moyá A; Bóveda J; de Lis JP; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):145-58. PubMed ID: 23181690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular risk of resistant hypertension: dependence on treatment-time regimen of blood pressure-lowering medications.
    Ayala DE; Hermida RC; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):340-52. PubMed ID: 23077973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [2013 Ambulatory blood pressure monitoring recommendations for the diagnosis of adult hypertension, assessment of cardiovascular and other hypertension-associated risk, and attainment of therapeutic goals (summary). Joint recommendations from the International Society for Chronobiology (ISC), American Association of Medical Chronobiology and Chronotherapeutics (AAMCC), Spanish Society of Applied Chronobiology, Chronotherapy, and Vascular Risk (SECAC), Spanish Society of Atherosclerosis (SEA), and Romanian Society of Internal Medicine (RSIM)].
    Hermida RC; Smolensky MH; Ayala DE; Portaluppi F; Crespo JJ; Fabbian F; Haus E; Manfredini R; Mojón A; Moyá A; Piñeiro L; Ríos MT; Otero A; Balan H; Fernández JR
    Clin Investig Arterioscler; 2013; 25(2):74-82. PubMed ID: 23849214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary albumin excretion at follow-up predicts cardiovascular outcomes in subjects with resistant hypertension.
    Oliveras A; Armario P; Sierra C; Arroyo JA; Hernández-del-Rey R; Vazquez S; Larrousse M; Sans L; Roca-Cusachs A; de la Sierra A
    Am J Hypertens; 2013 Sep; 26(9):1148-54. PubMed ID: 23747954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short sleep duration and type 2 diabetes enhance the risk of cardiovascular events in hypertensive patients.
    Eguchi K; Hoshide S; Ishikawa S; Shimada K; Kario K
    Diabetes Res Clin Pract; 2012 Dec; 98(3):518-23. PubMed ID: 23020940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of arterial functional evaluations as a predictor of cardiovascular events in hypertensive patients: the Non-Invasive Atherosclerotic Evaluation in Hypertension (NOAH) study.
    Terai M; Ohishi M; Ito N; Takagi T; Tatara Y; Kaibe M; Komai N; Rakugi H; Ogihara T
    Hypertens Res; 2008 Jun; 31(6):1135-45. PubMed ID: 18716361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visit-to-visit blood pressure variations: new independent determinants for cognitive function in the elderly at high risk of cardiovascular disease.
    Nagai M; Hoshide S; Ishikawa J; Shimada K; Kario K
    J Hypertens; 2012 Aug; 30(8):1556-63. PubMed ID: 22728907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Night-day blood pressure ratio and dipping pattern as predictors of death and cardiovascular events in hypertension.
    Fagard RH; Thijs L; Staessen JA; Clement DL; De Buyzere ML; De Bacquer DA
    J Hum Hypertens; 2009 Oct; 23(10):645-53. PubMed ID: 19225527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The combined contribution of albuminuria and glomerular filtration rate to the prediction of cardiovascular mortality in elderly men.
    Nerpin E; Ingelsson E; Risérus U; Sundström J; Larsson A; Jobs E; Jobs M; Hallan S; Zethelius B; Berglund L; Basu S; Arnlöv J
    Nephrol Dial Transplant; 2011 Sep; 26(9):2820-7. PubMed ID: 21335440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.